Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study

Psychiatry Res. 2023 Aug:326:115276. doi: 10.1016/j.psychres.2023.115276. Epub 2023 May 30.

Abstract

Innovative technology-based solutions have the potential to improve access to clinically proven interventions for cannabis use disorder (CUD) in individuals with first episode psychosis (FEP). High patient engagement with app-based interventions is critical for achieving optimal outcomes. 104 individuals 18 to 35 years old with FEP and CUD from three Canadian provinces completed an electronic survey to evaluate preferences for online psychological intervention intensity, participation autonomy, feedback related to cannabis use, and technology platforms and app functionalities. The development of the questionnaire was informed by a qualitative study that included patients and clinicians. We used Best-Worst Scaling (BWS) and item ranking methodologies to measure preferences. Conditional logistic regression models for BWS data revealed high preferences for moderate intervention intensity (e.g., modules with a length of 15 min) and treatment autonomy that included preferences for using technology-based interventions and receiving feedback related to cannabis use once a week. Luce regression models for rank items revealed high preferences for smartphone-based apps, video intervention components, and having access to synchronous communications with clinicians and gamification elements. Results informed the development of iCanChange (iCC), a smartphone-based intervention for the treatment of CUD in individuals with FEP that is undergoing clinical testing.

Keywords: App-based intervention; Best-Worst Scaling; Cannabis use disorder; Digital health; First episode psychosis; Mental health; Mobile health; Smartphone; Survey; Youth; eHealth; mHealth.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Canada
  • Cannabis*
  • Hallucinogens*
  • Humans
  • Mobile Applications*
  • Psychosocial Intervention
  • Psychotic Disorders* / psychology
  • Psychotic Disorders* / therapy
  • Young Adult

Substances

  • Hallucinogens

Grants and funding